World Health Organization: Tuberculosis factsheet No 104. 2011, Geneva, Switzerland: World Health Organization
Google Scholar
World Health Organization: TB Epidemiology and Surveillance Workshop. (Increasing/Decreasing Over/Under/Diagnosis of Extrapulmonary TB). 2005, Geneva, Switzerland
Google Scholar
Zhang X, Andersen AB, Lillebaek T, Kamper-Jorgensen Z, Thomsen VO, Ladefoged K, Marrs CF, Zhang L, Yang Z: Effect of sex, age, and race on the clinical presentation of tuberculosis: a 15-year population-based study. Am J Trop Med Hyg. 2011, 85: 285-290. 10.4269/ajtmh.2011.10-0630.
Article
PubMed
PubMed Central
Google Scholar
Nacci F, Matucci-Cerinic M: Tuberculosis and other infections in the anti-tumour necrosis factor-alpha (anti-TNF-alpha) era. Best Pract Res Clin Rheumatol. 2011, 25: 375-388. 10.1016/j.berh.2011.06.001.
Article
PubMed
Google Scholar
Blumberg HM, Burman WJ, Chaisson RE, Daley CL, Etkind SC, Friedman LN, Fujiwara P, Grzemska M, Hopewell PC, Iseman MD, Jasmer RM, Koppaka V, Menzies RI, O’Brien RJ, Reves RR, Reichman LB, Simone PM, Starke JR, Vernon AA: American Thoracic Society/Centers for Disease Control and Prevention/Infectious Diseases Society of America: treatment of tuberculosis. Am J Respir Crit Care Med. 2003, 167: 603-662.
Article
PubMed
Google Scholar
Shaw JE, Pasipanodya JG, Gumbo T: Meningeal tuberculosis: high long-term mortality despite standard therapy. Medicine (Baltimore). 2010, 89: 189-195. 10.1097/MD.0b013e3181df9070.
Article
Google Scholar
Thwaites GE, Simmons CP, Than Ha QN, Thi Hong CT, Phuong MP, Thi DN, Hoan PN, White NP, Tinh HT, Farrar JJ: Pathophysiology and prognosis in Vietnamese adults with tuberculous meningitis. J Infect Dis. 2003, 188: 1105-1115. 10.1086/378642.
Article
CAS
PubMed
Google Scholar
Thwaites GE, Bhavnani SM, Chau TT, Hammel JP, Torok ME, Van Wart SA, Mai PP, Reynolds DK, Caws M, Dung NT, Hien TT, Kulawy R, Farrar J, Ambrose PG: Randomized pharmacokinetic and pharmacodynamic comparison of fluoroquinolones for tuberculous meningitis. Antimicrob Agents Chemother. 2011, 55: 3244-3253. 10.1128/AAC.00064-11.
Article
CAS
PubMed
PubMed Central
Google Scholar
Thwaites GE, Nguyen DB, Nguyen HD, Hoang TQ, Do TT, Nguyen TC, Nguyen QH, Nguyen TT, Nguyen NH, Nguyen TN, Nguyen NL, Nguyen HD, Vu NT, Cao HH, Tran TH, Pham PM, Nguyen TD, Stepniewska K, White NJ, Tran TH, Farrar JJ: Dexamethasone for the treatment of tuberculous meningitis in adolescents and adults. N Engl J Med. 2004, 351: 1741-1751. 10.1056/NEJMoa040573.
Article
CAS
PubMed
Google Scholar
Ruslami R, Ganiem AR, Dian S, Apriani L, Achmad TH, van der Ven AJ, Borm G, Aarnoutse RE, Van CR: Intensified regimen containing rifampicin and moxifloxacin for tuberculous meningitis: an open-label, randomised controlled phase 2 trial. Lancet Infect Dis. 2013, 13: 27-35. 10.1016/S1473-3099(12)70264-5.
Article
PubMed
Google Scholar
Dutt AK, Moers D, Stead WW: Short-course chemotherapy for extrapulmonary tuberculosis: nine years’ experience. Ann Intern Med. 1986, 104: 7-10.7326/0003-4819-104-1-7.
Article
CAS
PubMed
Google Scholar
Kwara A, Roahen-Harrison S, Prystowsky E, Kissinger P, Adams R, Mathison J, Hyslop NE: Manifestations and outcome of extra-pulmonary tuberculosis: impact of human immunodeficiency virus co-infection. Int J Tuberc Lung Dis. 2005, 9 (5): 485-493.
CAS
PubMed
Google Scholar
Pasipanodya JG, Miller TL, Vecino M, Munguia G, Garmon R, Bae S, Drewyer G, Weis SE: Pulmonary impairment after tuberculosis. Chest. 2007, 131: 1817-1824. 10.1378/chest.06-2949.
Article
PubMed
Google Scholar
Pasipanodya JG, McNabb SJ, Hilsenrath P, Bae S, Lykens K, Vecino E, Munguia G, Miller TL, Drewyer G, Weis SE: Pulmonary impairment after tuberculosis and its contribution to TB burden. BMC Public Health. 2010, 10: 259-10.1186/1471-2458-10-259.
Article
PubMed
PubMed Central
Google Scholar
Arias E: United States life tables, 2004. National vital statistics reports. 2007, Hyattsville, MD: National Center for Health Statistics, Volume 56, 9
Google Scholar
Newton SM, Brent AJ, Anderson S, Whittaker E, Kampmann B: Paediatric tuberculosis. Lancet Infect Dis. 2008, 8: 498-510. 10.1016/S1473-3099(08)70182-8.
Article
PubMed
Google Scholar
Horsburgh CR, Goldberg S, Bethel J, Chen S, Colson PW, Hirsch-Moverman Y, Hughes S, Shrestha-Kuwahara R, Sterling TR, Wall K, Weinfurter P: Latent TB infection treatment acceptance and completion in the United States and Canada. Chest. 2010, 137: 401-409. 10.1378/chest.09-0394.
Article
PubMed
Google Scholar
Hermansen SW, Leitzmann MF, Schatzkin A: The impact on national death index ascertainment of limiting submissions to social security administration death master file matches in epidemiologic studies of mortality. Am J Epidemiol. 2009, 169: 901-908. 10.1093/aje/kwn404.
Article
PubMed
PubMed Central
Google Scholar
Park Y, Hartge P, Moore SC, Kitahara CM, Hollenbeck AR, De Berrington GA: Body mass index and mortality in non-Hispanic black adults in the NIH-AARP diet and health study. PLoS ONE. 2012, 7: e50091-10.1371/journal.pone.0050091.
Article
CAS
PubMed
PubMed Central
Google Scholar
Sesso HD, Paffenbarger RS, Lee IM: Comparison of national death index and world wide web death searches. Am J Epidemiol. 2000, 152: 107-111. 10.1093/aje/152.2.107.
Article
CAS
PubMed
Google Scholar
Pasipanodya JG, McIlleron H, Burger A, Wash PA, Smith P, Gumbo T: Serum drug concentrations predictive of pulmonary tuberculosis outcomes. J Infect Dis. 2013, 208: 1464-1473. 10.1093/infdis/jit352.
Article
CAS
PubMed
PubMed Central
Google Scholar
Lewis RJ: An introduction to classification and regression tree (CART) analysis. 2000 Annual Meeting of the Society for Academic Emergency Medicine. 2000, Des Plaines, IL: Society for Academic Emergency Medicine
Google Scholar
Steinberg D, Colla P: CART: Tree-Structured Non-parametric Data Analysis. 1995, San Diego: Salford Systems
Google Scholar
Breiman L, Friedman J, Stone CJ, Olshen RA: Classification and Regression Trees. 1984, Boca Raton: Chapman and Hall/CRC
Google Scholar
Breiman L: Prediction games and arcing algorithms. Neural Comput. 1999, 11: 1493-1517. 10.1162/089976699300016106.
Article
PubMed
Google Scholar
Breiman L: Technical note: some properties of splitting criteria. Mach Learn. 1996, 24: 41-47.
Google Scholar
Jain MK, Pasipanodya JG, Alder L, Lee WM, Gumbo T: Pegylated interferon fractal pharmacokinetics: individualized dosing for hepatitis C virus infection. Antimicrob Agents Chemother. 2013, 57: 1115-1120. 10.1128/AAC.02208-12.
Article
CAS
PubMed
PubMed Central
Google Scholar
Osler W: The Principles and Practice of Medicine. 1892, New York: Appleton, 1
Google Scholar
Canetti G: The tubercle bacillus in the pulmonary lesion of man. 1955, New York: Springer Publishing Company
Google Scholar
Koch R: Die atiologie der tuberkulose. Berliner Klinischen Wocheschrift. 1882, 15: 221-230.
Google Scholar
Canetti G, Grumbach F, Grosset J: Studies of bacillary populations in experimental tuberculosis of mice treated by isoniazid. Am Rev Respir Dis. 1960, 82: 295-313.
CAS
PubMed
Google Scholar
McCune RM, Feldmann FM, Lambert HP, McDermott W: Microbial persistence: I: the capacity of tubercle bacilli to survive sterilization in mouse tissues. J Exp Med. 1966, 123: 445-468. 10.1084/jem.123.3.445.
Article
CAS
PubMed
PubMed Central
Google Scholar
Tompsett R, McCune RM, Ormond L, Deuschle K, Muschenheim C, McDermott W: The influence of pyrazinamide-isoniazid on M. tuberculosis in animals and man. Trans Assoc Am Physicians. 1954, 67: 224-231.
CAS
PubMed
Google Scholar
Mitchison DA: Basic mechanisms of chemotherapy. Chest. 1979, 76: 771-781. 10.1378/chest.76.6_Supplement.771.
Article
CAS
PubMed
Google Scholar
Garton NJ, Waddell SJ, Sherratt AL, Lee SM, Smith RJ, Senner C, Hinds J, Rajakumar K, Adegbola RA, Besra GS, Butcher PD, Barer MR: Cytological and transcript analyses reveal fat and lazy persister-like bacilli in tuberculous sputum. PLoS Med. 2008, 5: e75-10.1371/journal.pmed.0050075.
Article
PubMed
PubMed Central
Google Scholar
Eum SY, Kong JH, Hong MS, Lee YJ, Kim JH, Hwang SH, Cho SN, Via LE, Barry CE: Neutrophils are the predominant infected phagocytic cells in the airways of patients with active pulmonary TB. Chest. 2010, 137: 122-128. 10.1378/chest.09-0903.
Article
PubMed
Google Scholar
Tiemersma EW, van der Werf MJ, Borgdorff MW, Williams BG, Nagelkerke NJ: Natural history of tuberculosis: duration and fatality of untreated pulmonary tuberculosis in HIV negative patients: a systematic review. PLoS ONE. 2011, 6: e17601-10.1371/journal.pone.0017601.
Article
CAS
PubMed
PubMed Central
Google Scholar
Katrak SM, Shembalkar PK, Bijwe SR, Bhandarkar LD: The clinical, radiological and pathological profile of tuberculous meningitis in patients with and without human immunodeficiency virus infection. J Neurol Sci. 2000, 181: 118-126. 10.1016/S0022-510X(00)00440-8.
Article
CAS
PubMed
Google Scholar
Shukla R, Abbas A, Kumar P, Gupta RK, Jha S, Prasad KN: Evaluation of cerebral infarction in tuberculous meningitis by diffusion weighted imaging. J Infect. 2008, 57: 298-306. 10.1016/j.jinf.2008.07.012.
Article
PubMed
Google Scholar
Gumbo T, Louie A, Deziel MR, Liu W, Parsons LM, Salfinger M, Drusano GL: Concentration-dependent Mycobacterium tuberculosis killing and prevention of resistance by rifampin. Antimicrob Agents Chemother. 2007, 51: 3781-3788. 10.1128/AAC.01533-06.
Article
CAS
PubMed
PubMed Central
Google Scholar
Gumbo T, Louie A, Liu W, Brown D, Ambrose PG, Bhavnani SM, Drusano GL: Isoniazid bactericidal activity and resistance emergence: integrating pharmacodynamics and pharmacogenomics to predict efficacy in different ethnic populations. Antimicrob Agents Chemother. 2007, 51: 2329-2336. 10.1128/AAC.00185-07.
Article
CAS
PubMed
PubMed Central
Google Scholar
Gumbo T, Siyambalapitiyage Dona CS, Meek C, Leff R: Pharmacokinetics-pharmacodynamics of pyrazinamide in a novel in vitro model of tuberculosis for sterilizing effect: a paradigm for faster assessment of new antituberculosis drugs. Antimicrob Agents Chemother. 2009, 53: 3197-3204. 10.1128/AAC.01681-08.
Article
CAS
PubMed
PubMed Central
Google Scholar
Srivastava S, Musuka S, Sherman C, Meek C, Leff R, Gumbo T: Efflux-pump-derived multiple drug resistance to ethambutol monotherapy in Mycobacterium tuberculosis and the pharmacokinetics and pharmacodynamics of ethambutol. J Infect Dis. 2010, 201: 1225-1231. 10.1086/651377.
Article
CAS
PubMed
PubMed Central
Google Scholar
Pasipanodya JG, Srivastava S, Gumbo T: Meta-analysis of clinical studies supports the pharmacokinetic variability hypothesis for acquired drug resistance and failure of antituberculosis therapy. Clin Infect Dis. 2012, 55: 169-177. 10.1093/cid/cis353.
Article
CAS
PubMed
PubMed Central
Google Scholar
Jeena PM, Bishai WR, Pasipanodya JG, Gumbo T: In silico children and the glass mouse model: clinical trial simulations to identify and individualize optimal isoniazid doses in children with tuberculosis. Antimicrob Agents Chemother. 2011, 55: 539-545. 10.1128/AAC.00763-10.
Article
CAS
PubMed
Google Scholar
Donald PR: Cerebrospinal fluid concentrations of antituberculosis agents in adults and children. Tuberculosis (Edinb). 2010, 90: 279-292. 10.1016/j.tube.2010.07.002.
Article
CAS
Google Scholar
Ge Z, Wang Z, Wei M: Measurement of the concentration of three antituberculosis drugs in the focus of spinal tuberculosis. Eur Spine J. 2008, 17: 1482-1487. 10.1007/s00586-008-0778-7.
Article
PubMed
PubMed Central
Google Scholar
Srivastava S, Pasipanodya JG, Meek C, Leff R, Gumbo T: Multidrug-resistant tuberculosis not due to noncompliance but to between-patient pharmacokinetic variability. J Infect Dis. 2011, 204: 1951-1959. 10.1093/infdis/jir658.
Article
CAS
PubMed
PubMed Central
Google Scholar
Thwaites G, Caws M, Chau TT, D’Sa A, Lan NT, Huyen MN, Gagneux S, Anh PT, Tho DQ, Torok E, Nhu NT, Duyen NT, Duy PM, Richenberg J, Simmons C, Hien TT, Farrar J: Relationship between Mycobacterium tuberculosis genotype and the clinical phenotype of pulmonary and meningeal tuberculosis. J Clin Microbiol. 2008, 46: 1363-1368. 10.1128/JCM.02180-07.
Article
CAS
PubMed
PubMed Central
Google Scholar
Caws M, Thwaites G, Dunstan S, Hawn TR, Lan NT, Thuong NT, Stepniewska K, Huyen MN, Bang ND, Loc TH, Gagneux S, Van SD, Kremer K, Van der SM, Small P, Anh PT, Chinh NT, Quy HT, Duyen NT, Tho DQ, Hieu NT, Torok E, Hien TT, Dung NH, Nhu NT, Duy PM, Van Vinh CN, Farrar J: The influence of host and bacterial genotype on the development of disseminated disease with Mycobacterium tuberculosis. PLoS Pathog. 2008, 4: e1000034-10.1371/journal.ppat.1000034.
Article
PubMed
PubMed Central
Google Scholar
Caws M, Thwaites G, Stepniewska K, Nguyen TN, Nguyen TH, Nguyen TP, Mai NT, Phan MD, Tran HL, Tran TH, Van SD, Kremer K, Nguyen VV, Nguyen TC, Farrar J: Beijing genotype of Mycobacterium tuberculosis is significantly associated with human immunodeficiency virus infection and multidrug resistance in cases of tuberculous meningitis. J Clin Microbiol. 2006, 44: 3934-3939. 10.1128/JCM.01181-06.
Article
CAS
PubMed
PubMed Central
Google Scholar
Ford CB, Shah RR, Maeda MK, Gagneux S, Murray MB, Cohen T, Johnston JC, Gardy J, Lipsitch M, Fortune SM: Mycobacterium tuberculosis mutation rate estimates from different lineages predict substantial differences in the emergence of drug-resistant tuberculosis. Nat Genet. 2013, 45: 784-790. 10.1038/ng.2656.
Article
CAS
PubMed
PubMed Central
Google Scholar
Esposito S, Esposito I, Leone S: Considerations of antibiotic therapy duration in community-and hospital-acquired bacterial infections. J Antimicrob Chemother. 2012, 67: 2570-2575. 10.1093/jac/dks277.
Article
CAS
PubMed
Google Scholar
Breiman L: Random forests. Mach Learn. 2001, 45: 5-32. 10.1023/A:1010933404324.
Article
Google Scholar